array:23 [
  "pii" => "S2173574310700022"
  "issn" => "21735743"
  "doi" => "10.1016/S2173-5743(10)70002-2"
  "estado" => "S300"
  "fechaPublicacion" => "2010-01-01"
  "aid" => "70002"
  "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología"
  "copyrightAnyo" => "2010"
  "documento" => "simple-article"
  "crossmark" => 0
  "subdocumento" => "edi"
  "cita" => "Reumatol Clin. 2010;6:3-4"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 502
    "formatos" => array:3 [
      "EPUB" => 37
      "HTML" => 328
      "PDF" => 137
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2173574310700034"
    "issn" => "21735743"
    "doi" => "10.1016/S2173-5743(10)70003-4"
    "estado" => "S300"
    "fechaPublicacion" => "2010-01-01"
    "aid" => "70003"
    "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2010;6:5-10"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 3070
      "formatos" => array:3 [
        "EPUB" => 43
        "HTML" => 1499
        "PDF" => 1528
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Hiperlaxity ligamentous (Beighton test) in the 8 to 12 years of age school population in the province of Granada"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "5"
          "paginaFinal" => "10"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Hiperlaxitud ligamentosa (test de Beighton) en la población escolar de 8 a 12 aĩos de la provincia de Granada"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Félix Zurita Ortega, Luis Ruiz Rodríguez, Asunción Martínez Martínez, Manuel Fernández Sánchez, Concepción Rodríguez Paiz, Remedios López Liriaa"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Félix"
              "apellidos" => "Zurita Ortega"
            ]
            1 => array:2 [
              "nombre" => "Luis"
              "apellidos" => "Ruiz Rodríguez"
            ]
            2 => array:2 [
              "nombre" => "Asunción"
              "apellidos" => "Martínez Martínez"
            ]
            3 => array:2 [
              "nombre" => "Manuel"
              "apellidos" => "Fernández Sánchez"
            ]
            4 => array:2 [
              "nombre" => "Concepción"
              "apellidos" => "Rodríguez Paiz"
            ]
            5 => array:2 [
              "nombre" => "Remedios"
              "apellidos" => "López Liriaa"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700034?idApp=UINPBA00004M"
    "url" => "/21735743/0000000600000001/v1_201305061603/S2173574310700034/v1_201305061603/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S2173574310700010"
    "issn" => "21735743"
    "doi" => "10.1016/S2173-5743(10)70001-0"
    "estado" => "S300"
    "fechaPublicacion" => "2010-01-01"
    "aid" => "70001"
    "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología"
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "edi"
    "cita" => "Reumatol Clin. 2010;6:1-2"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 1368
      "formatos" => array:3 [
        "EPUB" => 39
        "HTML" => 933
        "PDF" => 396
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Systemic lupus erythematosus. “What do we know and where are we heading?”"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "1"
          "paginaFinal" => "2"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Genética del lupus eritematoso generalizado. ¿Qué se sabe y a dónde se va?"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Marta Eugenia Alarcón Riquelme"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Marta Eugenia"
              "apellidos" => "Alarcón Riquelme"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700010?idApp=UINPBA00004M"
    "url" => "/21735743/0000000600000001/v1_201305061603/S2173574310700010/v1_201305061603/en/main.assets"
  ]
  "en" => array:9 [
    "idiomaDefecto" => true
    "titulo" => "New drugs for rheumatoid arthritis: The industry point of view"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "3"
        "paginaFinal" => "4"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Stephen H. Polmar"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "Stephen H."
            "apellidos" => "Polmar"
            "email" => array:1 [
              0 => "stephen@polmarconsulting.com"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Polmar Pharma Consulting, Woodbridge, Connecticut, USA"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Nuevos medicamentos contra la artritis reumatoide. El punto de vista de la industria"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:2 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K.G. Saag"
                            1 => "G.G. Teng"
                            2 => "N.M. Patkar"
                            3 => "J. Anuntiyo"
                            4 => "C. Finney"
                            5 => "J.R. Curtis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.23721"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2008"
                        "volumen" => "59"
                        "paginaInicial" => "762"
                        "paginaFinal" => "784"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18512708"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The PREMIER study: A multicenter, randomized, double-blind, clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F.C. Breedveld"
                            1 => "M.H. Weisman"
                            2 => "A.F. Kavanaugh"
                            3 => "S.B. Cohen"
                            4 => "K. Pavelka"
                            5 => "R. Van Vollenhoven"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.21519"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2006"
                        "volumen" => "54"
                        "paginaInicial" => "26"
                        "paginaFinal" => "37"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16385520"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000000600000001/v1_201305061603/S2173574310700022/v1_201305061603/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "17335"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000000600000001/v1_201305061603/S2173574310700022/v1_201305061603/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700022?idApp=UINPBA00004M"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

New drugs for rheumatoid arthritis: The industry point of view
Nuevos medicamentos contra la artritis reumatoide. El punto de vista de la industria
Stephen H. Polmar
Polmar Pharma Consulting, Woodbridge, Connecticut, USA
Read
3538
Times
was read the article
1742
Total PDF
1796
Total HTML
Share statistics
 array:23 [
  "pii" => "S2173574310700022"
  "issn" => "21735743"
  "doi" => "10.1016/S2173-5743(10)70002-2"
  "estado" => "S300"
  "fechaPublicacion" => "2010-01-01"
  "aid" => "70002"
  "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología"
  "copyrightAnyo" => "2010"
  "documento" => "simple-article"
  "crossmark" => 0
  "subdocumento" => "edi"
  "cita" => "Reumatol Clin. 2010;6:3-4"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 502
    "formatos" => array:3 [
      "EPUB" => 37
      "HTML" => 328
      "PDF" => 137
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2173574310700034"
    "issn" => "21735743"
    "doi" => "10.1016/S2173-5743(10)70003-4"
    "estado" => "S300"
    "fechaPublicacion" => "2010-01-01"
    "aid" => "70003"
    "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2010;6:5-10"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 3070
      "formatos" => array:3 [
        "EPUB" => 43
        "HTML" => 1499
        "PDF" => 1528
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Hiperlaxity ligamentous (Beighton test) in the 8 to 12 years of age school population in the province of Granada"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "5"
          "paginaFinal" => "10"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Hiperlaxitud ligamentosa (test de Beighton) en la población escolar de 8 a 12 aĩos de la provincia de Granada"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Félix Zurita Ortega, Luis Ruiz Rodríguez, Asunción Martínez Martínez, Manuel Fernández Sánchez, Concepción Rodríguez Paiz, Remedios López Liriaa"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Félix"
              "apellidos" => "Zurita Ortega"
            ]
            1 => array:2 [
              "nombre" => "Luis"
              "apellidos" => "Ruiz Rodríguez"
            ]
            2 => array:2 [
              "nombre" => "Asunción"
              "apellidos" => "Martínez Martínez"
            ]
            3 => array:2 [
              "nombre" => "Manuel"
              "apellidos" => "Fernández Sánchez"
            ]
            4 => array:2 [
              "nombre" => "Concepción"
              "apellidos" => "Rodríguez Paiz"
            ]
            5 => array:2 [
              "nombre" => "Remedios"
              "apellidos" => "López Liriaa"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700034?idApp=UINPBA00004M"
    "url" => "/21735743/0000000600000001/v1_201305061603/S2173574310700034/v1_201305061603/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S2173574310700010"
    "issn" => "21735743"
    "doi" => "10.1016/S2173-5743(10)70001-0"
    "estado" => "S300"
    "fechaPublicacion" => "2010-01-01"
    "aid" => "70001"
    "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología"
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "edi"
    "cita" => "Reumatol Clin. 2010;6:1-2"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 1368
      "formatos" => array:3 [
        "EPUB" => 39
        "HTML" => 933
        "PDF" => 396
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Systemic lupus erythematosus. “What do we know and where are we heading?”"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "1"
          "paginaFinal" => "2"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Genética del lupus eritematoso generalizado. ¿Qué se sabe y a dónde se va?"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Marta Eugenia Alarcón Riquelme"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Marta Eugenia"
              "apellidos" => "Alarcón Riquelme"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700010?idApp=UINPBA00004M"
    "url" => "/21735743/0000000600000001/v1_201305061603/S2173574310700010/v1_201305061603/en/main.assets"
  ]
  "en" => array:9 [
    "idiomaDefecto" => true
    "titulo" => "New drugs for rheumatoid arthritis: The industry point of view"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "3"
        "paginaFinal" => "4"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Stephen H. Polmar"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "Stephen H."
            "apellidos" => "Polmar"
            "email" => array:1 [
              0 => "stephen@polmarconsulting.com"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Polmar Pharma Consulting, Woodbridge, Connecticut, USA"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Nuevos medicamentos contra la artritis reumatoide. El punto de vista de la industria"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:2 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K.G. Saag"
                            1 => "G.G. Teng"
                            2 => "N.M. Patkar"
                            3 => "J. Anuntiyo"
                            4 => "C. Finney"
                            5 => "J.R. Curtis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.23721"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2008"
                        "volumen" => "59"
                        "paginaInicial" => "762"
                        "paginaFinal" => "784"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18512708"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The PREMIER study: A multicenter, randomized, double-blind, clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F.C. Breedveld"
                            1 => "M.H. Weisman"
                            2 => "A.F. Kavanaugh"
                            3 => "S.B. Cohen"
                            4 => "K. Pavelka"
                            5 => "R. Van Vollenhoven"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.21519"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2006"
                        "volumen" => "54"
                        "paginaInicial" => "26"
                        "paginaFinal" => "37"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16385520"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000000600000001/v1_201305061603/S2173574310700022/v1_201305061603/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "17335"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000000600000001/v1_201305061603/S2173574310700022/v1_201305061603/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700022?idApp=UINPBA00004M"
]
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 9 13 22
2024 October 36 34 70
2024 September 49 13 62
2024 August 53 34 87
2024 July 29 25 54
2024 June 30 16 46
2024 May 29 22 51
2024 April 23 25 48
2024 March 33 25 58
2024 February 17 23 40
2024 January 25 18 43
2023 December 16 26 42
2023 November 24 15 39
2023 October 24 25 49
2023 September 24 28 52
2023 August 22 10 32
2023 July 22 28 50
2023 June 20 18 38
2023 May 21 10 31
2023 April 20 10 30
2023 March 20 28 48
2023 February 20 32 52
2023 January 30 34 64
2022 December 23 31 54
2022 November 21 29 50
2022 October 22 32 54
2022 September 20 31 51
2022 August 45 42 87
2022 July 26 43 69
2022 June 30 34 64
2022 May 23 43 66
2022 April 28 38 66
2022 March 29 61 90
2022 February 15 29 44
2022 January 22 33 55
2021 December 25 36 61
2021 November 23 43 66
2021 October 75 45 120
2021 September 33 43 76
2021 August 12 43 55
2021 July 18 38 56
2021 June 29 41 70
2021 May 19 35 54
2021 April 66 84 150
2021 March 30 26 56
2021 February 26 24 50
2021 January 20 21 41
2020 December 13 13 26
2020 November 26 24 50
2020 October 13 15 28
2020 September 19 16 35
2020 August 16 18 34
2020 July 19 15 34
2020 June 23 19 42
2020 May 19 17 36
2020 April 20 20 40
2020 March 24 11 35
2020 January 4 0 4
2019 September 5 0 5
2019 June 2 0 2
2019 March 2 0 2
2019 January 1 0 1
2018 May 2 1 3
2018 April 14 12 26
2018 March 15 14 29
2018 February 17 5 22
2018 January 4 7 11
2017 December 6 5 11
2017 November 10 5 15
2017 October 17 4 21
2017 September 9 8 17
2017 August 10 11 21
2017 July 14 9 23
2017 June 16 7 23
2017 May 25 8 33
2017 April 15 3 18
2017 March 4 2 6
2017 February 0 1 1
2017 January 14 3 17
2016 December 31 8 39
2016 November 16 2 18
2016 October 24 8 32
2016 September 19 4 23
2016 August 20 6 26
2016 July 12 4 16
Show all

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?